Cleared Traditional

K233618 - Oxevision Sleep Device

K233618 is an FDA 510(k) clearance for Oxevision Sleep Device, manufactured by Oxehealth Limited. The device is a Class 2 Neurology device with product code LEL cleared through the Traditional 510(k) pathway after a 142-day FDA review.

K233618 · Oxehealth Limited · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2024
Decision
142d
Days
Class 2
Risk

K233618 is an FDA 510(k) clearance for the Oxevision Sleep Device. Classified as Device, Sleep Assessment (product code LEL), Class II - Special Controls.

Submitted by Oxehealth Limited (Oxford, GB). The FDA issued a Cleared decision on April 3, 2024 after a review of 142 days - within the typical 510(k) review window.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5050 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all Oxehealth Limited devices

FDA 510(k) Submission Details - K233618

510(k) Number K233618 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 13, 2023
Decision Date April 03, 2024
Days to Decision 142 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
6d faster than avg
Panel avg: 148d · This submission: 142d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LEL Device Classification - Class 2, Special Controls

Product Code LEL Device, Sleep Assessment
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.5050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - LEL Device, Sleep Assessment

All 9
Devices cleared under the same product code (LEL) and FDA review panel - the closest regulatory comparables to K233618.
Sleep Watch
K251574 · Ambulatory Monitoring, Inc. · Jul 2025
DCM (PW-DCM)
K243513 · Pneumowave, Ltd. · Apr 2025
VERABAND™
K233987 · Arbor Medical Innovations, LLC · Jun 2024
ActiGraph LEAP activity monitor (ActiGraph LEAP)
K231532 · Actigraph, LLC · Jun 2023
ActiGraph CentrePoint Insight Watch
K181077 · Actigraph · May 2018
EASYNET BODY POSITION MODULE
K040932 · Cadwell Laboratories, Inc. · Jul 2004